Abera Bioscience
6,80 SEK
-8,72 %
Mindre end 1K følgere
ABERA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
-8,72 %
0,00 %
-0,73 %
+1,49 %
-7,48 %
+62,29 %
+24,77 %
-
-38,46 %
Abera Bioscience operates in biotechnology. The company specializes in the development of vaccines based on a proprietary and patented platform. The technology is mainly used in the development of new vaccines, with a focus on the main areas of pneumococci and immuno-oncology. The operations are located throughout the Nordic market. The company was founded in 2012 and is headquartered in Solna.
Læs mereMarkedsværdi
126,68 mio. SEK
Aktieomsætning
238,51 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
12.2
2026
Årsrapport '25